Yue-min Nan

139 Ziqiang Road
Shijiazhuang, 050051, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Molecular mechanisms of FSP1-regulated ferroptosis and therapeutic implications in various cancers.

Molecular mechanisms of FSP1-regulated ferroptosis and therapeutic implications in various cancers.

Journal: Cellular & molecular biology letters

Published: February 05, 2026

Correction: Heme oxygenase-1 prevents non-alcoholic steatohepatitis through suppressing hepatocyte apoptosis in mice.

Correction: Heme oxygenase-1 prevents non-alcoholic steatohepatitis through suppressing hepatocyte apoptosis in mice.

Journal: Lipids in health and disease

Published: December 24, 2025

Intracellular IL-24 ameliorates lipid metabolic disorders in metabolic dysfunction-associated steatohepatitis by restoring the autophagy-lysosome pathway.

Intracellular IL-24 ameliorates lipid metabolic disorders in metabolic dysfunction-associated steatohepatitis by restoring the autophagy-lysosome pathway.

Journal: Cellular and molecular life sciences : CMLS

Published: July 12, 2025

LEAST as a novel prediction model of hepatocellular carcinoma development in patients with chronic hepatitis B: a multi-center study.

LEAST as a novel prediction model of hepatocellular carcinoma development in patients with chronic hepatitis B: a multi-center study.

Journal: BMC medicine

Published: May 12, 2025

Combined DeRitis ratio and alkaline phosphatase on the prediction of portal vein tumor thrombosis in patients with hepatocellular carcinoma.

Combined DeRitis ratio and alkaline phosphatase on the prediction of portal vein tumor thrombosis in patients with hepatocellular carcinoma.

Journal: Scientific reports

Published: October 23, 2023

Consensus on the tertiary prevention of primary liver cancer.

Consensus on the tertiary prevention of primary liver cancer.

Journal: Hepatology international

Published: February 11, 2023

Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B.

Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B.

Journal: Journal of clinical and translational hepatology

Published: February 08, 2022

Correction to: Consensus on the secondary prevention of primary liver cancer.

Correction to: Consensus on the secondary prevention of primary liver cancer.

Journal: Hepatology international

Published: December 11, 2021

Hepatic Macrophage activation and the LPS pathway in patients with different degrees of severity and histopathological patterns of drug induced liver injury.

Hepatic Macrophage activation and the LPS pathway in patients with different degrees of severity and histopathological patterns of drug induced liver injury.

Journal: Histology and histopathology

Published: April 19, 2021

The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease.

The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease.

Journal: Journal of hepatology

Published: January 04, 2021

Co-administration of obeticholic acid and simvastatin protects against high-fat diet-induced non-alcoholic steatohepatitis in mice.

Co-administration of obeticholic acid and simvastatin protects against high-fat diet-induced non-alcoholic steatohepatitis in mice.

Journal: Experimental and therapeutic medicine

Published: October 19, 2020

Plasma Golgi protein 73 levels predict prognosis of HCV-related hepatic fibrosis.

Plasma Golgi protein 73 levels predict prognosis of HCV-related hepatic fibrosis.

Journal: Histology and histopathology

Published: October 16, 2020

Showing 1-12 of 31

Last Updated: 09/26/2026